Subscribe
spot_img

Articles

HomeArticles

Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026

As aesthetic dermatology continues to evolve beyond isolated procedures toward a more holistic, patient-centered model, industry leaders are increasingly focused on how innovation,...
Aesthetics Magazine Editorial - 0

Journal Digest: January 14, 2026

0

NPF Position Statement Aligns Severity Classification With Treatment Needs

Psoriasis severity classification plays a central role in treatment selection, insurance authorization, and clinical trial eligibility. For decades, severity has largely been defined...
Aesthetics Magazine Editorial - 0

Utilizing CYP2C9 Testing and JAK Inhibitors for Alopecia Areata

0

― Advertisement ―

spot_img

Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026

As aesthetic dermatology continues to evolve beyond isolated procedures toward a more holistic, patient-centered model, industry leaders are increasingly focused on how innovation,...

More News

Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026

As aesthetic dermatology continues to evolve beyond isolated procedures toward a more holistic, patient-centered model, industry leaders are increasingly focused on how innovation,...

Journal Digest: January 14, 2026

Journal of Dermatological Treatment | Oral Finasteride Use and Sexual Adverse Events: Signal Detection from Disproportionality Analyses of Data from the United States...

NPF Position Statement Aligns Severity Classification With Treatment Needs

Psoriasis severity classification plays a central role in treatment selection, insurance authorization, and clinical trial eligibility. For decades, severity has largely been defined...
spot_img

Explore more

Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026

Aesthetics Magazine Editorial -
As aesthetic dermatology continues to evolve beyond isolated procedures toward a more holistic, patient-centered model, industry leaders are increasingly focused on how innovation,...

Journal Digest: January 14, 2026

Aesthetics Magazine Editorial -
Journal of Dermatological Treatment | Oral Finasteride Use and Sexual Adverse Events: Signal Detection from Disproportionality Analyses of Data from the United States...

NPF Position Statement Aligns Severity Classification With Treatment Needs

Aesthetics Magazine Editorial -
Psoriasis severity classification plays a central role in treatment selection, insurance authorization, and clinical trial eligibility. For decades, severity has largely been defined...

Utilizing CYP2C9 Testing and JAK Inhibitors for Alopecia Areata

Aesthetics Magazine Editorial -
In Irvine, California, Natasha A. Mesinkovska, MD, Associate Professor and Vice Chair for Clinical Research, Dermatology at University of California, Irvine, led a Dermatology...

Timing, Severity, and Therapeutic Choice in Moderate to Severe HS

Aesthetics Magazine Editorial -
Hidradenitis suppurativa (HS) continues to challenge clinicians with its heterogeneity, chronic progression, and profound impact on patients’ lives. Although treatment algorithms provide structure,...

Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026

Aesthetics Magazine Editorial -
As aesthetic dermatology continues to evolve beyond isolated procedures toward a more holistic, patient-centered model, industry leaders are increasingly focused on how innovation,...

Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors

Aesthetics Magazine Editorial -
Tyrosine kinase 2 (TYK2) is a key intracellular signaling mediator within the Janus kinase–signal transducer and activator of transcription (JAK–STAT) pathway and plays...

Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT

Aesthetics Magazine Editorial -
This month, Alpha Tau Medical has announced the submission of the first module of its Pre-Market Approval (PMA) application to the US Food...

Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials

Aesthetics Magazine Editorial -
Recludix Pharma has announced the initiation of clinical dosing in a first-in-human phase 1 study of REX-8756 (SAR448755), an oral, small-molecule inhibitor of...

Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications

Aesthetics Magazine Editorial -
Interleukin-4 (IL-4) and interleukin-13 (IL-13) are central drivers of type 2 inflammation across multiple diseases, including atopic dermatitis (AD), asthma, and chronic obstructive...

Insights from the Multinational RWEAL Study on CHE Etiology, Severity, and Real-World Management

Aesthetics Magazine Editorial -
Despite the prevalence and profound impact on patient quality of life and occupational productivity, data regarding how chronic hand eczema (CHE) is managed...

Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026

Aesthetics Magazine Editorial -
As aesthetic dermatology continues to evolve beyond isolated procedures toward a more holistic, patient-centered model, industry leaders are increasingly focused on how innovation,...
123...8Page 1 of 8

Subscribe for exclusive content

We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.

Subscribe

Copyright SEOEvaluate, Aesthetics Magazine.